Diane Finegood
Affiliations: | Simon Fraser University, Burnaby, British Columbia, Canada |
Area:
Physiology Biology, Neuroscience BiologyGoogle:
"Diane Finegood"Mean distance: 53433
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Suskin NG, Heigenhauser G, Afzal R, et al. (2007) The effects of exercise training on insulin resistance in patients with coronary artery disease. European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups On Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology. 14: 803-8 |
| Hamilton J, Cummings E, Zdravkovic V, et al. (2003) Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial. Diabetes Care. 26: 138-43 |
| Legro RS, Finegood D, Dunaif A. (1999) A Fasting Glucose To Insulin Ratio Is A Useful Measure Of Insulin Sensitivity In Women With Polycystic Ovary Syndrome Obstetrical & Gynecological Survey. 54: 35-36 |
| Legro RS, Finegood D, Dunaif A. (1998) A Fasting Glucose to Insulin Ratio Is a Useful Measure of Insulin Sensitivity in Women with Polycystic Ovary Syndrome The Journal of Clinical Endocrinology and Metabolism. 83: 2694-2698 |
| Dunaif A, Scott D, Finegood D, et al. (1997) The Insulin-Sensitizing Agent Troglitazone Improves Metabolic and Reproductive Abnormalities in the Polycystic Ovary Syndrome Obstetrical & Gynecological Survey. 52: 110-111 |
| Dunaif A, Scott D, Finegood D, et al. (1996) The Insulin-Sensitizing Agent Troglitazone Improves Metabolic and Reproductive Abnormalities in the Polycystic Ovary Syndrome* The Journal of Clinical Endocrinology and Metabolism. 81: 3299-3306 |
| Kneteman NM, Lakey JRT, Wagner T, et al. (1996) The metabolic impact of rapamycin (sirolimus) in chronic canine islet graft recipients Transplantation. 61: 1206-1210 |
| Hramiak I, Dupre J, Finegood D. (1992) Determinants of prolonged (> 1 year) Non-Insulin-Receiving (NIR) remission of IDDM during cyclosporine A (CsA treatment) Journal of Autoimmunity. 5 |